Helixate NexGen regulatory update

On Dec. 20, 2013, EMA's CHMP endorsed recommendations from the agency's Pharmacovigilance Risk Assessment Committee (PRAC) that the benefits of Kogenate Bayer and Helixate NexGen from Bayer outweigh ...